| Literature DB >> 28386193 |
Mingsan Miao1, Ting Wang2, Xin Lou2, Peng Xi2, Baosong Liu2, Bingjie Chang2.
Abstract
To study the influence of stachydrine hydrochloride on the inflammatory cytokines and tissue morphology of the re-perfusion model of mice with repetitive cerebral ischemia and probe into the protection mechanism of stachydrine hydrochloride for cerebral ischemia reperfusion impairment. Build a repetitive cerebral ischemia reperfusion model by first blocking the common carotid artery on both sides for 10 min, then resuming perfusion for 10 min and then blocking the common carotid artery on both sides again for 10 min. Before the operation, all the mice in the Nimodipine group, and the big, medium and small stachydrine hydrochloride dose groups were given corresponding gastric perfusion, the mice in the sham operation group and the modeled groups were at the same time given 0.5% sodium carboxymethyl cellulose for gastric perfusion of the same volume. The medicine was fed daily for 7 consecutive days. The model was built 1 h after the last feed and the perfusion continued for 24 h after the operation. Then the death rate of the mice was calculated. The mouse brains were taken out to test the ICAM-1 level and the TNF-α level, and the serum was taken out to test the NSE level and the MPO level. The tissue morphology changes were also observed. All the repetitive cerebral ischemia reperfusion models were successfully duplicated. The stachydrine hydrochloride in all the dose groups significantly reduced the death rates of big and small mice, reduced the level of ICAM-1 and the level of TNF-α in the brain tissues and the NSE level and the MPO level in the serum, significantly alleviating the pathological impairment in the hippocampus. Stachydrine hydrochloride can significantly reduce the death rate of mice, improve the pathological changes in the hippocampus, inhibit inflammatory reactions after ischemia, thus reducing the re-perfusion impairment after cerebral ischemia.Entities:
Keywords: Cerebral ischemia reperfusion; Stachydrine hydrochloride
Year: 2017 PMID: 28386193 PMCID: PMC5372397 DOI: 10.1016/j.sjbs.2017.01.039
Source DB: PubMed Journal: Saudi J Biol Sci ISSN: 2213-7106 Impact factor: 4.219
The influence on the death rate, serum NSE and serum MPO levels of the modeled mice ( ± s).
| Group | Dose (mg/kg) | Number of animals modeling | Death rate (%) | NSE (ng/ml) | MPO (U/L) | |
|---|---|---|---|---|---|---|
| Before | Post | |||||
| Sham-operation group | – | 16 | 16 | 0 | 4.401 ± 0.587** | 66.808 ± 24.759** |
| Model group | – | 16 | 10 | 37.5 | 5.401 ± 0.546 | 118.964 ± 38.892 |
| Nimodipine group | 30 | 16 | 12 | 25 | 4.848 ± 0.539* | 86.806 ± 27.390* |
| Big-dose group | 60 | 16 | 13 | 18.75 | 4.892 ± 0.410* | 79.679 ± 23.303** |
| Medium-dose group | 30 | 16 | 11 | 31.25 | 4.929 ± 0.493* | 82.838 ± 26.744** |
| Small-dose group | 15 | 16 | 11 | 31.25 | 5.046 ± 0.476 | 85.493 ± 33.322* |
Note: Compared with the modeled group, **P < 0.01, *P < 0.05.
Influence on the ICAM-1 and TNF-α level of the cerebral tissue of the mice ( ± s).
| Group | Dose (mg/kg) | ICAM-1 (ng/ml) | TNF-α (pg/ml) | |
|---|---|---|---|---|
| Sham-operation group | 16 | – | 63.239 ± 14.605** | 85.539 ± 10.305** |
| Model group | 10 | – | 81.204 ± 14.328 | 104.431 ± 14.311 |
| Nimodipine group | 12 | 30 | 69.048 ± 9.816** | 91.275 ± 8.210** |
| Big-dose group | 13 | 60 | 69.826 ± 9.783* | 90.965 ± 11.694** |
| Medium-dose group | 11 | 30 | 71.861 ± 10.636* | 93.316 ± 9.824* |
| Small-dose group | 11 | 15 | 72.259 ± 9.162 | 94.973 ± 8.421* |
Note: Compared with the modeled group, **P < 0.01, *P < 0.05.
Figure 1The pathological photos of the cerebral cortex of modeled mice.
The influence on the pathological changes in the cerebral cortex of the modeled mice.
| Group | Dose (mg/kg) | − | + | ++ | +++ | ||
|---|---|---|---|---|---|---|---|
| Sham-operation group | 16 | – | 16 | 0 | 0 | 0 | ** |
| Model group | 10 | – | 0 | 0 | 2 | 8 | |
| Nimodipine group | 12 | 30 | 5 | 4 | 2 | 1 | ** |
| Big-dose group | 13 | 60 | 3 | 6 | 3 | 1 | ** |
| Medium-dose group | 11 | 30 | 3 | 4 | 3 | 1 | ** |
| Small-dose group | 11 | 15 | 2 | 5 | 2 | 2 | ** |
Note: Compared with the modeled group, **P < 0.01, *P < 0.05.
“−” the nerve cells were normal; “+” cerebral cortex nerve cells had edema, were interspersed, a small amount of neurons degenerated, the cytoplasm was lightly dyed and the structure blurred; “++” the nerve cells in the cerebral cortex had edema, chunks of neurons degenerated, the cytoplasm was lightly dyed, the structure blurred and certain neurons were necrotic; “+++” the cerebral cortex nerve cells had edema and most neurons were necrotic.
The influence on the pathological changes in the hippocampus of the modeled mice.
| Group | Dose (mg/kg) | − | + | ++ | +++ | ||
|---|---|---|---|---|---|---|---|
| Sham-operation group | 16 | – | 16 | 0 | 0 | 0 | ** |
| Model group | 10 | – | 0 | 0 | 3 | 7 | |
| Nimodipine group | 12 | 30 | 4 | 3 | 3 | 2 | ** |
| Big-dose group | 13 | 60 | 3 | 4 | 5 | 1 | ** |
| Medium-dose group | 11 | 30 | 2 | 3 | 4 | 2 | ** |
| Small-dose group | 11 | 15 | 1 | 2 | 5 | 3 | * |
Note: Compared with the modeled group, **P < 0.01,*P < 0.05.
“−” the nerve cells were normal; “+” hippocampus nerve cells had edema, were interspersed, a small amount of neurons degenerated, the cytoplasm was lightly dyed and the structure blurred; “++” the nerve cells in the hippocampus had edema, chunks of neurons degenerated, the cytoplasm was lightly dyed, the structure blurred and certain neurons were necrotic; “+++” the hippocampus nerve cells had edema and most neurons were necrotic.